中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
13期
65-65,66
,共2页
噻托溴铵%沙美特罗替卡松%慢性阻塞性肺疾病
噻託溴銨%沙美特囉替卡鬆%慢性阻塞性肺疾病
새탁추안%사미특라체잡송%만성조새성폐질병
tiotropium bromine%salmeterol fluticasone propionate%chronic obstructive pulmonary disease
目的：观察联合吸入噻托溴铵与沙美特罗替卡松对老年重度稳定慢性阻塞性肺疾病（COPD）的疗效。方法将50例老年重度稳定COPD患者分为两组，对照组采用噻托溴铵进行治疗，治疗组采用噻托溴铵联合沙美特罗替卡进行治疗，比较两组患者的肺功能改善情况和圣乔治呼吸间歇问题调查问卷（SGRQ）评分。结果治疗组的肺功能改善情况和SGRQ评分均显著优于对照组（ P﹤0.05）。结论老年重度稳定COPD采用噻托溴铵联合沙美特罗替卡松治疗可改善患者的临床症状，且安全有效。
目的：觀察聯閤吸入噻託溴銨與沙美特囉替卡鬆對老年重度穩定慢性阻塞性肺疾病（COPD）的療效。方法將50例老年重度穩定COPD患者分為兩組，對照組採用噻託溴銨進行治療，治療組採用噻託溴銨聯閤沙美特囉替卡進行治療，比較兩組患者的肺功能改善情況和聖喬治呼吸間歇問題調查問捲（SGRQ）評分。結果治療組的肺功能改善情況和SGRQ評分均顯著優于對照組（ P﹤0.05）。結論老年重度穩定COPD採用噻託溴銨聯閤沙美特囉替卡鬆治療可改善患者的臨床癥狀，且安全有效。
목적：관찰연합흡입새탁추안여사미특라체잡송대노년중도은정만성조새성폐질병（COPD）적료효。방법장50례노년중도은정COPD환자분위량조，대조조채용새탁추안진행치료，치료조채용새탁추안연합사미특라체잡진행치료，비교량조환자적폐공능개선정황화골교치호흡간헐문제조사문권（SGRQ）평분。결과치료조적폐공능개선정황화SGRQ평분균현저우우대조조（ P﹤0.05）。결론노년중도은정COPD채용새탁추안연합사미특라체잡송치료가개선환자적림상증상，차안전유효。
Objective To investigate the effect of combined inhalation of tiotropium bromine and salmeterol fluticasone propionate for treating senile severe stable chronic obstructive pulmonary disease ( COPD ) . Methods 50 cases of senile severe stable COPD were ran-domly divided into two groups. The control group was treated by tiotropium bromine, while the treatment group adopted the inhalation treatment of tiotropium bromine and salmeterol fluticasone propionate. The improvement of the lung function and the scores of the St. George Respiratory Questionnaire ( SGRQ ) were compared between the two groups. Results The lung function improvement and the SGRQ scores after therapy in the treatment group were superior to those in the control group with the statistical the difference between them ( P﹤ 0. 05 ) . Conclusion Adopting tiotropium bromine combined with salmeterol fluticasone propionate for treating senile severe stable COPD can improve the patient's clinical symptoms and is safe and effective.
